StockpollyBeta
Get App
Delisting riskPopularity #5,231
NXTS · NASDAQ · Agricultural Inputs

N2OFF (NXTS)

Develops mitochondrial transporter drug candidates and European solar and storage projects.

$1.48
After hours+0.05 (+3.50%)
At close$1.43(+3.62%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
321111131181
Research & development200000000000
121111131021
Selling & marketing000000000000
General & administrative000000131020
Other expenses000000000060
Operating income−3−2−1−1−1−1−1−3−1−1−8−2
0000−10−1−2221−10
Interest income000000000000
Interest expense000000110000
Other non-operating income000000010−2−10
Income before tax−3−2−1−1−2−1−1−502−7−11
Income tax expense000000000000
Net income from continuing operations−3−2−1−1−2−1−1−502−7−11
Discontinued operations000000000−110
Net income−2−2−1−1−2−1−1−501−7−11
EPS, basic−$435.42−$181.12−$9.10−$7.86−$12.91−$3.98−$2.58−$6.40$3.15$1.87−$10.74−$13.66
EPS, diluted−$435.42−$181.12−$9.10−$7.86−$12.91−$3.98−$2.58−$6.40$3.15$1.87−$10.74−$13.66
Weighted average shares, basic000000010011
Weighted average shares, diluted000000010011
EBITDA−3−2−1−1−1−1−1−3−11−7−1
Depreciation & amortization000000000000
EBIT−3−2−1−1−1−1−1−3−11−7−2